20 news items
From Comfort to Cure: 2024 ASCO Meeting Reveals Groundbreaking Oncology Data
ABBV
AZN
BMY
19 Jun 24
of metastatic PDAC patients may benefit from pelareorep-based therapy."
Funded
From Comfort to Cure: 2024 ASCO Meeting Reveals Groundbreaking Oncology Data
ABBV
AZN
BMY
19 Jun 24
range of metastatic PDAC patients may benefit from pelareorep-based therapy."
Funded
U.S. FDA Approves SKYRIZI® (risankizumab-rzaa) for Ulcerative Colitis, Expanding AbbVie's Portfolio Across Inflammatory Bowel Disease
ABBV
18 Jun 24
with:
moderate to severe plaque psoriasis who may benefit from taking injections or pills (systemic therapy) or treatment
Pharma Stock Roundup: FDA Panel Endorses LLY's Donanemab, PFE's DMD Therapy Study Fails
ABBV
AZN
LLY
14 Jun 24
meaningful slowing of disease progression for early symptomatic Alzheimer's patients. Overall, the committee voted that the benefits of donanemab
Goldman Sachs Optimistic About Regenxbio's Gene Therapy Pipeline, Sees Over 160% Upside
ABBV
FDMT
REGN
7 Jun 24
such as the risk/benefit balance of fewer anti-VEGF injections compared to the potential for inflammation and steroid use and how this approach differs
x1yf11qj53j9w0xecru
ABBV
CI
CVS
7 Jun 24
biosimilars.
Following their launch last year, pharmacy benefit managers largely influenced patient access, with minimal incentive for doctors
80or8vm29l56quhab hf16ku1f38
ABBV
ABOS
ALXO
6 Jun 24
that all of its licensees will benefit from this patent. The patent is set to be validated in 37 EU countries, where it will be legally recognized
qzeuans0a51z2vxra6fwdmgf6aka3ll3na6dsn7 cg5809
ABBV
6 Jun 24
that Elahere treatment resulted in an overall survival benefit and reduced the risk of cancer progression by 35%.
Elahere represents
c9i16g
ABBV
6 Jun 24
-based chemotherapy remains the most active treatment for earlier lines of ovarian cancer. The benefit of retreatment with platinum is generally less
7g7b78t3yt3t4lzuyn8uy7xmmcpjr3wud722gw
ABBV
ALXO
ANVS
3 Jun 24
-endoscopic mucosal improvement.
Per AbbVie, endoscopic improvement may lead to potential long-term benefits, including lower risk
sfyidzloxk0j9mv3ct4o2jxqlvhwp9vhusouxzegaxwcbufwoij7zaj
ABBV
CYTO
ONCY
24 May 24
positive outcome, an even broader range of metastatic PDAC patients may benefit from pelareorep-based therapy. This cohort is being funded by a US$5
3peknrkcvhm2hajzfs be46c2oefwyqx6yh8o5ajryeumfa9gocic
ABBV
AMGN
CURLF
18 May 24
(OTC:CURLF). Additionally, DEA-authorized studies on cannabis benefits will advance research and development, potentially leading
6pznka bq1
ABBV
17 May 24
to severe plaque psoriasis who may benefit from taking injections or pills (systemic therapy) or treatment using ultraviolet or UV light (phototherapy
rt7xdpnuwk2pqw0b0zca9v22bkt0h6o0e4c98we1wsaj9kngbd5pa 0pyw8n
ABBV
13 May 24
-generation versions known as neuroplastogens target mechanisms that have shown potential to provide significant clinical benefits and are designed
hiyp6oqxlp7b8h5d6nb2tehd0igy0iywhxoi06
ABBV
CI
CVS
26 Apr 24
Health’s Inc (NYSE:CVS) pharmacy benefits unit took Humira off
xe6jheaet4cnd0qw2v0sefoxf651z hmq1e2a4hkztyivhexohvepdmhi
ABBV
AVTX
LLY
16 Apr 24
IL-1α and IL-1β, showed substantial benefits in Phase 2 trials for a severe HS group.
Additionally, MAS825 from Novartis
ugcqjirky6dqq0p
ABBV
12 Apr 24
. Studies have shown that CGRP levels are elevated during migraine attacks and selective CGRP receptor antagonists confer clinical benefit in migraine
b89lr
ABBV
FGEN
3 Apr 24
an imaging agent called 89Zr-based CD46 PET to select patients most likely to benefit from FG-3246 in the Phase 2 study.
FibroGen
h9mgfxrb84c5rb 6avqoxk1vxhjeva1
ABBV
25 Mar 24
medicine approaches for drug development. This ensures that patients receive therapies that are most likely to benefit them according to their unique
1uyqjd8i6
ABBV
22 Mar 24
) - Data show that ELAHERE treatment resulted in an overall survival benefit and reduced the risk of cancer progression by 35
- Prev
- 1
- Next